Browse by Profession PharmaciesHospitalsDoctorsPatientsManufacturers

News for Global

Global News

BiCNU - Masters working in partnership with Emcure

Masters Pharmaceuticals Limited is pleased to announce its partnership with Emcure Pharmaceuticals Limited. The agreement, commencing 29th  April, 2013, will enable patients and healthcare professionals in the Caribbean, Middle East, Africa and Latin America to access BiCNU®  (INN: Carmustine for injection). 

Healthcare Distribution Management Association (HDMA)

Masters Medical Inc (MMI) based in Florida is pleased to announce that it has become a member of the Healthcare Distribution Management Association (HDMA). This affliliation will provide additional resource to further strengthen the Masters supply chain and enhance the services we provide to our valued customers.

Masters, focused on providing the Patient, wherever they are, access to the best available treatments.

 
  
Master . . ,

Systemic Mastocytosis and Mast Cell Activation Syndrome - sodium cromoglicate 100mg Tablets

Masters Pharmaceuticals Ltd is pleased to announce the availability of sodium cromoglicate 100mg Tablets for the alleviation of the symptoms of Systemic Mastocytosis and Mast Cell Activation Syndrome.
Please see the information below regarding supply:

LORAZEPAM Injection 4mg/ml - Available from Masters Pharmaceuticals Limited.

Masters Pharmaceuticals Limited in the United Kingdom is pleased to announce the availability of Lorazepam Injection 4mg/mL.

Presentation: Lorazepam Injection 4mg/mL is supplied as 1mL vials in packs of 25

 

Clinical Trials

Masters sources Comparator Drugs for all phases of a Clinical Trial, and prides itself on providing the highest standard of Comparator Sourcing available. In addition to this, Masters also has a Controlled Drug Licence, which enables us to source controlled substances for Clinical Trials when needed.

Not only do Masters get involved in the planning process of supplying Comparator Drugs, but we also help our customers reduce their wastage and costs, by only supplying Comparator Drugs as and when they are needed throughout the Trials process.

Masters always has a detailed knowledge of the manufacturer that it uses to source its Comparator Drugs, and maintains security throughout its Supply Chain, to guarantee against counterfeit dangers. Furthermore, Masters can also provide unusual dosage requirements if or when required, and even have the ability to supply Comparator Drugs in the event that a product is no longer commercialised.
By partnering with Masters, Biotech and Pharmaceutical companies have full confidence that they can conduct a trial to the highest clinical standards, and always have full support from us throughout each stage of a Clinical Trial.
 
 

Masters Clinical Trials Procurement Strategy:

  • Confidential, reliable sourcing of Comparator Drugs from across the world and across all therapeutic sectors
  • Meeting full Regulatory Standards
  • Providing all necessary product documentation
  • Guaranteeing only genuine products are sourced, and providing full Batch Traceability
  • Working closely with Clients, Masters ensures that Comparator Sourcing is planned early in the trial process to mitigate the risks of over/under ordering, and potential wastage.
  • Providing peace of mind and flexibility, enabling the Client  to concentrate on initiating the Trial
Our unparallel service in Clinical Trial Procurement ensures that your trial meets international standards and is conducted in a timely manner. We understand that a delay in comparator drugs not only delays the trial, but also endangers patient lives by preventing access to life-saving drugs.

If you wish to discuss your company’s comparator requirements, please refer to our Relevant Contacts for Clinical Trials.